Huseby NE - Search Results

1

Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.

Hansen JB, Sandset PM, Huseby KR, Huseby NE, Nordøy A. Hansen JB, et al. Among authors: huseby kr, huseby ne. Thromb Haemost. 1996 Nov;76(5):703-9. Thromb Haemost. 1996. PMID: 8950777

2

Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.

Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bønaa KH. Hansen JB, et al. Thromb Res. 2001 Apr 1;102(1):3-13. doi: 10.1016/s0049-3848(01)00215-8. Thromb Res. 2001. PMID: 11323009

3

Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia.

Hansen JB, Huseby KR, Huseby NE, Sandset PM, Hanssen TA, Nordøy A. Hansen JB, et al. Among authors: huseby kr, huseby ne. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):879-85. doi: 10.1161/01.atv.15.7.879. Arterioscler Thromb Vasc Biol. 1995. PMID: 7600119

4

Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma.

Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordøy A. Hansen JB, et al. Among authors: huseby ne. Arterioscler Thromb. 1994 Feb;14(2):223-9. doi: 10.1161/01.atv.14.2.223. Arterioscler Thromb. 1994. PMID: 8305412 Clinical Trial.

5

Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro.

Hansen JB, Huseby KR, Huseby NE, Ezban M, Nordøy A. Hansen JB, et al. Among authors: huseby kr, huseby ne. Thromb Res. 1997 Mar 1;85(5):413-25. doi: 10.1016/s0049-3848(97)00029-7. Thromb Res. 1997. PMID: 9076898

6

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.

Hansen JB, Sandset PM, Huseby KR, Huseby NE, Bendz B, Ostergaard P, Nordøy A. Hansen JB, et al. Among authors: huseby kr, huseby ne. Br J Haematol. 1998 Jun;101(4):638-46. doi: 10.1046/j.1365-2141.1998.00770.x. Br J Haematol. 1998. PMID: 9674734 Free article. Clinical Trial.

7

Increased resistance towards oxidative stress accompanies enhancement of metastatic potential obtained by repeated in vivo passage of colon carcinoma cells in syngeneic rats.

Andreassen K, Mortensen B, Winberg JO, Huseby NE. Andreassen K, et al. Among authors: huseby ne. Clin Exp Metastasis. 2002;19(7):623-9. doi: 10.1023/a:1020978411846. Clin Exp Metastasis. 2002. PMID: 12498392

8

Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.

Mikkelsen IM, Huseby NE, Visvikis A, Moens U. Mikkelsen IM, et al. Among authors: huseby ne. Biochem Pharmacol. 2002 Jul 15;64(2):307-15. doi: 10.1016/s0006-2952(02)01116-4. Biochem Pharmacol. 2002. PMID: 12123752

9

Ultrastructure of reperfused skeletal muscle: the effect of oxygen radical scavenger enzymes.

Ytrehus K, Reikerås O, Huseby N, Myklebust R. Ytrehus K, et al. Int J Microcirc Clin Exp. 1995 Jul-Aug;15(4):155-62. doi: 10.1159/000178970. Int J Microcirc Clin Exp. 1995. PMID: 8847175

10

Nitric oxide exposure of CC531 rat colon carcinoma cells induces gamma-glutamyltransferase which may counteract glutathione depletion and cell death.

Huseby NE, Asare N, Wetting S, Mikkelsen IM, Mortensen B, Sveinbjørnsson B, Wellman M. Huseby NE, et al. Free Radic Res. 2003 Jan;37(1):99-107. doi: 10.1080/1071576021000036434. Free Radic Res. 2003. PMID: 12653223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page